‘It’s time to invest in cell-based treatment for nuclear exposure’
The head of the Haifa-based clinical-stage cell therapy company said Pluristem has developed the most advanced technology to treat people suffering from exposure to high levels of radiation.
PLURISTEM CO-CEO Yaky Yanay speaks at the Jerusalem Post Diplomatic Conference in the capital’s Waldorf Astoria on Wednesday about his company’s groundbreaking work combating potential radiation catastrophes.(photo credit: SIVAN FARAG)ByMAAYAN JAFFE-HOFFMANUpdated:
